The Ratings Game: Pfizer, Eli Lilly, Bristol-Myer and J&J initiated with buy ratings by Goldman Sachs 0 28.05.2019 22:02 MarketWatch.com Goldman Sachs started coverage of some big drug stocks on Tuesday in a bullish note. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа